ArticleMetabolic brain disease2026
Neurobiology of co-morbid stress and a western diet in mice: mitochondrial, proteomic and behavioral outcomes.
Article in Metabolic brain disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic stress (CS) and hyper-caloric diets promote affective disorders, however pathobiological interactions await definition. Neurobiological and behavioral influences of chronic stress (CS; 2 h/day restraint for 2 wks) were studied in male C57Bl/6 mice fed a control diet (CD; 12% kcal as fat/65% carbohydrate/23% protein) or Western diet (WD; 32% kcal fat/57% carbohydrate/11% protein) for 20 wks. CS induced weight loss and anxiety-like behavior, associated with reduced frontal cortex (FC) brain-derived neurotrophic factor (BDNF) and γ-aminobutyric acid (GABA) vs. elevated glutamate; and mitochondrial dysfunction, including reduced complex I (CI), electron transport system (ETS) and spare respiratory capacities. Hippocampus (HPC) appeared less responsive (CI flux selectively inhibited). Proteomics supports CS disruption of synaptogenesis and mitochondrial pathways, together with “adaptive” changes, including activation of neuroprotective chaperone-mediated autophagy (CMA), reelin and eukaryotic initiation factor 2 (EIF2) paths. The WD alone (inducing weight gain, insulin-resistance and reduced sucrose preference) had no independent effects on FC neurochemistry, FC or HPC respiratory function. Co-morbid CS in WD mice induced anxiety-like behavior and anhedonia, coupled with WD-related reductions in FC GABA and HPC BDNF not evident in un-stressed mice. A co-morbid WD also limited CS-dependent changes in ETS and spare respiratory capacities. Proteomics supports reduced CS activation of reelin and EIF2 pathways, and a switch from CMA activation to suppression, in co-morbid CS + WD mice. Summary: Mild anxiogenic stress disrupts mitochondrial function, glutamate:GABA balance and BDNF/synaptogenesis signaling, primarily in FC vs. HPC. Co-morbid CS + WD exaggerates neurochemical disturbances, and disrupts adaptive pathway responses, in association with anhedonia and anxiety-like behaviors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.